- Founded in 2002, we are a peer-reviewed journal publishing articles on all aspects of lipids, aiming to bridge the gap between the lab and the clinic.
- Open access publication ensures that your article can be easily discovered, accessed, used, and shared, maximising your impact and acting as a springboard for further discovery.
- Our editorial team provides a swift and professional service in support of our submitting authors.
- We provide high levels of author satisfaction, with 90% of our published authors reporting that they would definitely or probably publish with us again.
Aims and scope
Lipids in Health and Disease is an open access, peer-reviewed journal that publishes articles on all aspects of lipids: their interaction with proteins, (bio) chemistry, (molecular) pharmacology, (molecular) toxicology, natural products chemistry, role in health and disease, in addition to the synthesis of new lipid compounds, and enzyme systems involved in lipid metabolism.
Lipids in Health and Disease is aimed at all scientists, health professionals, and physicians interested in lipids. Lipids are defined herein based on their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes, and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology, and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.
Why publish your article in Lipids in Health and Disease?
All articles published by Lipids in Health and Disease are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Lipids in Health and Disease you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Lipids in Health and Disease therefore levies an article-processing charge of £1570.00/$2290.00/€1790.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
For more information on APCs please see our Journal Pricing FAQs
All articles published in Lipids in Health and Disease are included in:
- Food Science and Technology Abstracts
- Global Health
- PubMed Central
- Science Citation Index Expanded
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Lipids in Health and Disease operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
Lipids in Health and Disease considers the following types of article: Research, Review, Commentary, Hypothesis, and Short report. For more specific information, please take a look at our Submission Guidelines.
All manuscripts submitted to Lipids in Health and Disease should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appeals and complaints
Citing articles in Lipids in Health and Disease
Articles in Lipids in Health and Disease should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Lipids Health Dis [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Lipids Health Dis 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Benefits of publishing with BMC
Lipids in Health and Disease's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Lipids in Health and Disease offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Lipids in Health and Disease gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Lipids in Health and Disease are included in article alerts and regular email updates. Some may be highlighted on Lipids in Health and Disease’s pages and on the BMC homepage.
In addition, articles published in Lipids in Health and Disease may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Lipids in Health and Disease. A list of articles recently press-released by journals published by BMC is available here.
As an author of an article published in Lipids in Health and Disease you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).
For further information about the advantages of publishing in a journal from BMC, please click here.
Annual Journal Metrics
60 days to first decision for reviewed manuscripts only
39 days to first decision for all manuscripts
139 days from submission to acceptance
16 days from acceptance to publication
629 Altmetric Mentions